文献速递睡眠呼吸障碍小儿耳鼻咽喉

优化Inspire舌下神经刺激器设置治疗儿童阻塞性睡眠呼吸暂停

Optimizing Inspire Hypoglossal Nerve Stimulator Settings in Pediatric Obstructive Sleep Apnea.
PubMed 文献 · Laryngoscope · 2024-06-25

该研究描述三例经严格筛选的唐氏综合征合并阻塞性睡眠呼吸暂停患儿,在舌下神经刺激(HGNS)标准刺激设置滴定未能降低呼吸暂停低通气指数(AHI)后,采用优化刺激与感知导联设置的进阶滴定算法,必要时结合药物诱导睡眠内镜(DISE),结果三例AHI均降低约50%或以上,两例达到AHI<5。

要点

  • 对标准刺激设置滴定无反应的唐氏综合征合并OSA患儿,优化感知导联设置可能进一步降低AHI。
  • 以低通气为主的睡眠研究可分配至进阶滴定,以阻塞性呼吸暂停为主者转诊行DISE。
  • 进阶滴定后三例AHI均降低约50%或以上,两例达到AHI<5。

核心结论

  • 针对Inspire HGNS系统的新型诊断与治疗滴定算法,在标准设备滴定仅关注刺激设置未能起效的三例唐氏综合征合并OSA患儿中显著降低了AHI。

研究设计与样本

  • 病例系列,纳入三例经筛选的唐氏综合征合并OSA患儿,均初始HGNS治疗未能降低AHI。
  • 两例睡眠研究以低通气为主者接受进阶滴定(优化刺激设置与感知导联设置),第三例以阻塞性呼吸暂停为主者转诊行DISE。

主要发现

  • 应用进阶滴定算法后,三例患儿AHI均降低约50%或以上。
  • 两例患儿达到「正常至轻度OSA」的AHI水平(AHI<5)。

关键数值与推荐

  • 进阶滴定包括调整刺激设置和感知导联设置。
  • 滴定算法根据阻塞性呼吸暂停为主与低通气为主的睡眠模式进行选择。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hypoglossal nerve stimulation (HGNS) is an effective therapy for carefully selected pediatric patients with Down syndrome (DS) and obstructive sleep apnea (OSA), but optimization of device settings has been focused on stimulation settings. The potential benefits of sensing lead setting optimization have not been investigated. We describe a series of three cases of HGNS in children with DS where optimization of both the stimulation lead and sensing lead settings, as well as utilization of drug-induced sleep endoscopy (DISE), when indicated, was more effective than stimulation lead optimization alone. METHODS: Using our novel titration algorithm, among the three identified pediatric patients with DS in whom HGNS initially failed to reduce the apnea-hypopnea index (AHI), two patients in whom sleep studies were characterized as hypopnea-dominant were assigned to advanced titration (optimization of stimulation settings and sensing lead settings). The third patient, with an obstructive apnea-dominant sleep study, was referred for interrogated DISE. Advanced titration included adjustment of both stimulation settings and sensing lead settings. RESULTS: Application of the advanced titration algorithm, tailored to obstructive apnea- versus hypopnea-dominant sleep patterns, resulted in approximately 50% or greater reduction in AHI in all three patients. "Normal to mild OSA" AHI (AHI <5) was achieved in two patients. CONCLUSIONS: A novel diagnostic and therapeutic titration algorithm for the Inspire HGNS system significantly reduced AHI in three pediatric patients with DS and OSA who had failed to respond to the standard device titration that focused solely on stimulation settings. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:5164-5169, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Marcus KS, Larrow DR, Gipson KS, et al. Optimizing Inspire Hypoglossal Nerve Stimulator Settings in Pediatric Obstructive Sleep Apnea. Laryngoscope. 2024. PMID: 38922916. doi:10.1002/lary.31600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。